• PA
    PA School SurvivalDidactic Year
Study
  • Dashboard
  • Medical Terminology
  • Flashcards
  • Progress
  • Prep Rounds
  • Body Systems
  • Pharmacology
  • Tools
  • Guide & FAQ
  • Suggest a FeatureLet us know what we can do better — we genuinely want to help you in class.
My material
  • My Library
  • Notes & Sketches
PANCE Body Systems
  • Cardiovascular
    11%
  • Pulmonary
    9%
  • Gastrointestinal/Nutrition
    8%
  • Musculoskeletal
    8%
  • Neurology
    7%
  • Infectious Disease
    7%
  • Psychiatry/Behavioral
    7%
  • Reproductive
    7%
  • Endocrine
    6%
  • Eyes/Ears/Nose/Throat
    6%
  • Hematology
    5%
  • Renal
    5%
  • Genitourinary
    4%
  • Dermatology
    4%
Weights are study aids — verify each exam cycle.
⌘K
NotesPricingSign in
About·Tools·Terminology·Privacy Policy·Terms of Service·PANCE Blueprint

PANCE® is a registered trademark of the National Commission on Certification of Physician Assistants (NCCPA). This application is an independent study resource and is not affiliated with, sponsored by, or endorsed by the NCCPA.

For educational use only. Content is AI-generated, may contain errors, and is not medical advice — always verify against current primary sources and faculty guidance before clinical use.

Flashcards

Active recall over every profile. Pick a scope, reveal, and self-grade — “Again” sends a card back to the end of the deck.

Card 1 of 6
DiseasePulmonary

Asthma

Recall: Pathophysiology · S/Sx · Gold Standard Dx · First-line Tx · Pearl

Tap or press Space to reveal
DiseasePulmonary

Asthma

Pathophysiology
Airway inflammation + bronchial hyperresponsiveness → reversible bronchoconstriction, mucus, and edema.
S/Sx
Episodic wheeze, cough, chest tightness, dyspnea; worse at night/with triggers; prolonged expiration.
Gold Standard Dx
Spirometry: obstructive pattern (↓ FEV1/FVC) with ≥12% reversibility after a bronchodilator.
First-line Tx
Inhaled corticosteroid (ICS) is the controller foundation; current guidelines favor as-needed ICS-formoterol (SMART) as the preferred reliever over a SABA alone. Step up controller therapy (add LABA) by symptom control.

Reversibility on spirometry separates asthma from COPD. Every asthmatic needs ICS-containing therapy — guidelines now favor ICS-formoterol as reliever, not SABA monotherapy.